Skip to content

Medical device manufacturer

Remel, Inc.

Remel, Inc. holds 154 FDA 510(k) clearances across 42 product codes. Median elapsed review time is 53 days. openFDA lists 113 recall records naming the company. FDA publishes it under 10 different spellings, all counted here as one company.

Updated · ingest status · JSON

510(k) clearances
154
Product codes
42
Median review
53 days
Recall records
113

How does FDA spell Remel, Inc.?

FDA publishes this company under 10 different spellings across its datasets. Every figure on this page counts all of them as one company, which is why the totals here are higher than a search for any single spelling would give you.

Every spelling FDA published for this company, and which dataset each came from.
As FDA published itDatasetMatched by
REMEL, INC.device/registrationlistingnormalised
Remel Co.device/510knormalised
Remel Incdevice/enforcementnormalised
Remel Incdevice/recallnormalised
Remel Inc.device/enforcementnormalised
Remel Inc.device/recallnormalised
Remel, Incdevice/enforcementnormalised
Remel, Incdevice/recallnormalised

Showing 8 of 10.

Merges are measured against a hand-labelled sample and held above 98% precision. Pairs the matcher is unsure of are queued for a person rather than merged, because two genuinely different firms with similar names is the error that would corrupt every count on this page.

Which product codes does Remel, Inc. file in?

42 product codes, ranked by how much they file in each.

Product codes this company holds clearances in, with their median elapsed review time in each.
CodeDeviceClearancesMedian reviewLatest
JTODiscs, Strips And Reagents, Microorganism Differentiation4959 days
JTNSusceptibility Test Discs, Antimicrobial1463 days
JTSStains, Microbiologic1251 days
JSJCulture Media, Selective And Non-Differential1139 days
JSICulture Media, Selective And Differential929 days
JSMCulture Media, Non-Propagating Transport530 days
JSOCulture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar5179 days
LIODevice, Specimen Collection557 days
JSFCulture Media, Single Biochemical Test437 days
JSNCulture Media, Propagating Transport232 days
JTLPlasma, Coagulase, Human, Horse And Rabbit231 days
JWYManual Antimicrobial Susceptibility Test Systems242 days
JXBKit, Identification, Yeast289 days
LLHReagents, Clostridium Difficile Toxin2115 days
MHIGiardia Spp.2147 days
MJDCulture Media, Antimycobacteria, Susceptibility Test217 days
GNAAntisera, All Types, Escherichia Coli1280 days
GNXAntigens, Cf (Including Cf Control), Influenza Virus A, B, C123 days
GROAntisera, Fluorescent, All Types, Hemophilus Spp.139 days
HYIIodine, Grams18 days
IDCAcridine Orange144 days
IGBSolution, Formalin-Sodium Acetate120 days
JFOFluorometric, Calcium1109 days
JIOBlood, Occult, Colorimetric, In Urine170 days
JSDCulture Media, Selective Broth130 days

Showing the 25 they file in most, of 42.

Median review is elapsed calendar days between date received and decision date, as published by FDA. It is not FDA review days — the two differ whenever the agency stops the clock for an additional information request.

Source: openFDA device/510k · retrieved

Has Remel, Inc. had a recall?

openFDA lists 113 recall records naming this company across its whole history, of which 4 were opened in the last 12 months and are not yet marked terminated. A recall record covers one firm's corrective action and may span many device lots.

  • Z-2623-2026Class IIOpen, ClassifiedJTY

    Reduced or no recovery of some strains of Neisseria gonorrhoeae.

  • Z-1806-2026Class IIOpen, ClassifiedNGZ

    Products may report incorrect AST results during quality control. Health consequences may include delayed response or the need to change to another antifungal agent if laboratory ignores Quality Control test result.

  • Z-1474-2026Class IIOpen, ClassifiedJSJ

    Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium.

  • Z-0585-2026Class IIOpen, ClassifiedJTZ

    Products may contain contamination, which may result in a darker or brown media color.

  • Z-2223-2025Class IIOpen, ClassifiedJSH

    The products may contain surface and subsurface contamination of Listeria monocytogenes.

Showing the 5 most recently initiated of 113.

Recall class comes from openFDA's enforcement endpoint, which does not carry every recall — where it is missing, none is shown rather than guessed. Recall class I is the most serious kind of recall; device class I is the least risky kind of device, and the two are never mixed here.

Source: openFDA device/recall · retrieved

What has Remel, Inc. cleared recently?

Most recent 510(k) clearances for this company, newest first.
510(k)DeviceCodeDecisionElapsed days
K162620Remel Spectra ESBLJSO223
K131804REMEL XPECT FLU A&BGNX23
K092407REMEL SPECTRA MRSAJSO428
K072827RPMI 1640 AGAR W/MOPS AND 2% GLUCOSEMJE54
K041951XPECT CLOSTRIDIUM DIFFICILE TOXIN A/BLLH118
K033479PROSPECT CLOSTRIDIUM DIFFICILE TOXIN A/B MICROPLATE ASSAYLLH115
K031942XPECT GIARDIA LATERAL FLOW ASSAY, MODEL 2450020MHI147
K031965XPECT CRYPTOSPORIDIUM LATERAL FLOW ASSAY, MODEL 2451020MHJ141
K031834XPECT GIARDIA/CRYPTOSPORIDIUM LATERAL FLOW ASSAYMHI150
K031565XPECT INFLUENZA A/BPSZ59

Source: openFDA device/510k · retrieved

Where is Remel, Inc. registered?

FDA lists 1 registered establishment for this company in US.

Registration means the firm has told FDA it makes or distributes devices from that site. It is not a clearance, an approval or an endorsement.

Watch what Remel, Inc. files next

Get an email when this company clears a new device, or when anything is recalled in a product code you follow.

Start watching with DeviceSignal

Data on this page comes from FDA's public openFDA API and is US public domain (CC0). DeviceSignal is an independent commercial service and is not affiliated with the U.S. Food and Drug Administration. Information only, not regulatory advice. Verify anything you rely on against open.fda.gov.